Mazdutide for treating PCOS
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial is testing a new medication called Mazdutide to help treat PCOS in women with obesity. It aims to see if it improves PCOS symptoms and related health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index (BMI) must be 28 or higher.
- You must not plan to get pregnant for at least 8 months after joining the study.
- You need to have at least two of these PCOS signs: irregular periods, polycystic ovaries on ultrasound, or high testosterone levels or excess hair growth.
- You cannot have had pancreatitis, medullary thyroid cancer (or family history), severe high triglycerides, diabetes, or other hormone-related conditions.
- You must not be pregnant, breastfeeding, or have serious heart, liver, kidney, or other major organ disease or any cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a team of doctors from different specialties can better diagnose and treat PCOS. If you have PCOS and are looking for a more comprehensive approach, this study may be a good fit.
This study looks at hormone levels and metabolism in people who may have polycystic ovary syndrome (PCOS). It aims to better understand why PCOS happens, which could help improve future diagnosis and treatment.
This study tests whether the weight-loss drug orlistat can improve blood sugar, hormones, and other metabolic measures in women with polycystic ovary syndrome (PCOS). If you have PCOS and are overweight, this treatment might help with symptoms like irregular periods and excess hair growth.
This study tests a new medication that combines two hormone-like drugs to treat polycystic ovary syndrome (PCOS), a condition affecting ovulation and hormone balance. The trial aims to see if this dual-action drug can improve irregular periods and other PCOS symptoms better than current treatments.
This study tests a once-weekly injection called mazdutide to help adults with prediabetes and higher weight lower their blood sugar and potentially lose weight. It is a double-blind, placebo-controlled trial, meaning some people get the real drug and some get a placebo (no active drug).
This study tests if tirzepatide (a once-weekly injection) can improve periods and metabolic health in women with PCOS who are overweight. If you have PCOS, irregular cycles, and a BMI of 27 or higher, you might qualify.
Hear when a new Polycystic Ovary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.